filmov
tv
Mechanisms of ALK Resistance & Implications for Treatment
Показать описание
Acquired Resistance Forum Video #8: Dr. Robert Doebele of the University of Colorado Cancer Center spoke to ALK and ROS1 patients about how and why their cancers become resistant to treatment and what options are available.
GRACEcast 281 Lung
Mechanisms of ALK Resistance & Implications for Treatment
Dr Nandini Menon - Molecular Resistance Mechanism Of ALK Inhibitors
CRSF 07th Masterclass: Mechanisms of Resistance to ALK Inhibitors | Dr. Nandini Menon
Resistance Mechanisms in ALK-Rearranged NSCLC
Mechanisms of TKI resistance
Resistance to ALK TKIs
Mechanisms of Resistance to EGFR TKI and New Treatment Strategies
How Ensartinib Works in ALK-Positive Non-Small Cell Lung Cancer: Mechanism Explained │ PHARMACOLOGY...
NSCLC: How to Handle ALK Resistance
2023 Best of Lung: Targeted Therapies in Lung Cancer
Keynote Lecture: Targeted Therapies in Lung Cancer 2.0 – Advances and Promises
Enigma (Elucidating Novel Immune and Genomic Markers for ALK) with Drs. Gainor and Lin.
Shaw Patterns of Resistance in ALK Positive NSCLC
Next-generation ALK inhibitors: treatment sequencing and resistance
Gene Targeted Therapy for Non Small Cell Lung Cancer
ALK TKI Side Effects and Acquired Resistance - 2022 Program: Targeted Therapies Forum
Targeting ALK - From Discovery to Frontline Treatment
Current & Emerging Approaches to Acquired Resistance for ALK/ROS1
What is Acquired Resistance to Targeted Therapy, and Why Does it Occur?
New Ideas and New Treatment Options for Acquired Resistance for ALK/ROS1
ALK Positive Lung Cancer in 2023 and Beyond: Thinking Outside the Box with Dr. Alice Shaw
Ceritinib and Alectinib in Relapsed ALK+ NSCLC
First and Second Generation ALK Inhibitors for the Treatment of Lung Cancer
Ceritinib and Other Second Generation ALK Inhibitors for Acquired Resistance in ALK-Positive NSCLC
Комментарии